lobbying_activities: 1226069

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1226069	e3b9698f-b159-4923-bdeb-9e5aa7d1fb0c	Q1	DENNY MILLER ASSOCIATES	25328	CELL THERAPEUTICS	2012	first_quarter	PHA	Prescription Drug User Fee Act Reauthorization (no number), provisions relating to approval of new drugs. H.R. 4132 - Faster Access to Specialized Treatments Act, all sections; S. 2113 Transforming the Regulator Environment to Accelerate Access to Treatments, all sections.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2012-04-13T10:03:25.597000-04:00